These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9398213)

  • 1. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
    Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
    Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 3D models of octopus estrogen receptor with estradiol: evidence for steric clashes that prevent estrogen binding.
    Baker ME; Chandsawangbhuwana C
    Biochem Biophys Res Commun; 2007 Sep; 361(3):782-8. PubMed ID: 17678875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
    J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-binding properties of estrogen receptor proteins after interaction with surface-immobilized Zn(II) ions: evidence for localized surface interactions and minimal conformational changes.
    Hutchens TW; Li CM
    J Mol Recognit; 1990 Aug; 3(4):174-9. PubMed ID: 2278734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational dynamics and molecular recognition: backbone dynamics of the estrogen receptor DNA-binding domain.
    Wikström A; Berglund H; Hambraeus C; van den Berg S; Härd T
    J Mol Biol; 1999 Jun; 289(4):963-79. PubMed ID: 10369775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
    Hurth KM; Nilges MJ; Carlson KE; Tamrazi A; Belford RL; Katzenellenbogen JA
    Biochemistry; 2004 Feb; 43(7):1891-907. PubMed ID: 14967030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptors alpha and beta exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA.
    Tyulmenkov VV; Klinge CM
    Arch Biochem Biophys; 2001 Jun; 390(2):253-64. PubMed ID: 11396928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational dynamics of estrogen receptors alpha and beta as revealed by intrinsic tryptophan fluorescence and circular dichroism.
    Nair SK; Thomas TJ; Greenfield NJ; Chen A; He H; Thomas T
    J Mol Endocrinol; 2005 Oct; 35(2):211-23. PubMed ID: 16216903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation.
    Kani K; Park E; Landgraf R
    Biochemistry; 2005 Dec; 44(48):15842-57. PubMed ID: 16313187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA binding domain of estrogen receptor alpha is required for high-affinity nuclear interaction induced by estradiol.
    Weinberg AL; Carter D; Ahonen M; Alarid ET; Murdoch FE; Fritsch MK
    Biochemistry; 2007 Aug; 46(31):8933-42. PubMed ID: 17630774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor interaction with immobilized metals: differential molecular recognition of Zn2+, Cu2+ and Ni2+ and separation of receptor isoforms.
    Hutchens TW; Li CM
    J Mol Recognit; 1988 Apr; 1(2):80-92. PubMed ID: 3273655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment.
    Zhao C; Toresson G; Xu L; Koehler KF; Gustafsson JA; Dahlman-Wright K
    Biochemistry; 2005 Jun; 44(22):7936-44. PubMed ID: 15924412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin decreases the estrogen binding capacity of the estrogen receptor.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1996 Oct; 227(3):651-7. PubMed ID: 8885989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
    Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation.
    Yudt MR; Vorojeikina D; Zhong L; Skafar DF; Sasson S; Gasiewicz TA; Notides AC
    Biochemistry; 1999 Oct; 38(43):14146-56. PubMed ID: 10571988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
    Wurtz JM; Egner U; Heinrich N; Moras D; Mueller-Fahrnow A
    J Med Chem; 1998 May; 41(11):1803-14. PubMed ID: 9599231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.